Research service to report on prevention of drug use and policy developments of relevance to the drug situation in Ireland for Ireland’s EMCDDA National Focal Point 2021-23

of its calls state an estimated value

100%

Ireland · Research & development

different companies won awards here

162

of the awards went to the three most frequent winners

8%

winners of the last 12 months were new here

84 of 92

buyers awarded contracts here

76

Based on 196 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.

Competition

tenders per lot on average (open and restricted procedures)

5.3

of those lots received a single tender

13%

of the awards went to companies based in another country

27%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.